Thai hospital tycoon sticks to guns on vaccine claims
BANGKOK, July 16 (Reuters) – Thailand’s Thonburi Healthcare Group Pcl (THG) (THG.BK) doubled down on its outspoken chairman’s claim to be buying Pfizer-BioNTech vaccines on Friday, helping its share price rise despite denials by both drugmakers.
Dr. Boon Vanasin’s claim that his group, a more than $800 million private medicine empire, was close to signing a deal for 20 million Pfizer-BioNTech (PFE.N), (22UAy.DE) coronavirus vaccines to import to Thailand was swiftly denied on Thursday by both companies, one day after a government agency filed a defamation suit against Boon, 82. read more
On Friday, THG stuck to its guns.
“THG has agreed to buy the vaccine and is currently in the process of filing documents with overseas dealers,” the company said in a statement.
Boon even told local media an agreement would be signed by Friday afternoon. By close of business, there was still no evidence of any deal.
THG shares closed 1.59% higher, having been up as much as 4% at one point.
It’s still unclear whether Boon was insincere, the victim of a scam or – as he asserts – in the process of a brilliant fix to Thailand’s desperate vaccine needs.
Boon insists a deal was in the works through a government agency, which he declined to name.
“We are not doing it directly,” he told Reuters.
Still, his comments on Thursday added about 1.5 billion baht ($45.80 million) to THG’s market capitalisation, bring it to 26.8 billion baht ($818.32 million), Refinitiv Eikon data shows.
Thailand so far has only vaccinated 5 percent of its population of more than 66 million. It has been administering China’s Sinovac vaccine and the AstraZeneca’s shots but the government seeking other imported doses.
Boon, the Thai word for merit, has been on a quest for COVID-19 vaccines for months, arguing that the government should not monopolise supply and calling the vaccine policy “complacent and reckless.”
In February, he tried to import vaccines, but was unsuccessful and later lodged a protest. read more .
Months later state drugmaker, the Government Pharmaceutical Organization (GPO), said it would import five million doses of Moderna vaccine (MRNA.O) for private hospitals read more .
Demand for mRNA vaccines in Thailand is growing. Pre-orders for Moderna vaccines through private hospitals were snapped up in a hurry. read more
Boon criticised the GPO for its process and on Wednesday the GPO slapped a defamation suit against the John Hopkins-trained physician. He said he welcomed the complaint because evidence and documents could be revealed in court. read more
Boon founded Thonburi hospital in 1976 and oversaw its expansion into a network of seven hospitals with 963 registered beds. He took the company public in 2017.
THG, which also operates hospitals in Cambodia and Myanmar, booked losses of 215 million baht in the first quarter this year, taking a hit from the pandemic and drop off in medical tourists.
The group is smaller than rivals like Bangkok Dusit Medical Services Pcl (BDMS.BK), and before the pandemic, its chairman began to carve out a niche. In 2017, he launched a $500 million ‘medical city’ for the elderly called Jin Wellbeing County, targeting Thailand’s ageing population and foreign retirees.
Reporting by Chayut Setboonsarng; Editing by Simon Cameron-Moore
Our Standards: The Thomson Reuters Trust Principles.